Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY Project
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
Our News
Events
Contact us
News
Invivyd announces positive phase 1/2 clinical data for VYD2311, a monoclonal antibody to be a alternative to COVID-19 vaccination for the broad population
07 February 2025
This new drug delivery method could offer long-lasting relief for eye diseases
07 February 2025
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents
31 January 2025
Narrating medicine: Experiences of HIV treatment and prevention
31 January 2025
Health Canada approves (Pr)ABILIFY ASIMTUFII® (aripiprazole), the first, once-every-two-months, long-acting injectable treatment for schizophrenia
24 January 2025
UNAIDS calls on leaders at Davos to commit to rapid global access to revolutionary new long-acting HIV medicines
24 January 2025
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
17 January 2025
Long-acting Injectables: Microsphere Design, Development and Scale-up Using Lactide/Glycolide-Based Polymers, Upcoming Webinar Hosted by Xtalks
17 January 2025
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
17 January 2025
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral
17 January 2025
News
Invivyd announces positive phase 1/2 clinical data for VYD2311, a monoclonal antibody to be a alternative to COVID-19 vaccination for the broad population
07 February 2025
This new drug delivery method could offer long-lasting relief for eye diseases
07 February 2025
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents
31 January 2025
Narrating medicine: Experiences of HIV treatment and prevention
31 January 2025
Health Canada approves (Pr)ABILIFY ASIMTUFII® (aripiprazole), the first, once-every-two-months, long-acting injectable treatment for schizophrenia
24 January 2025
UNAIDS calls on leaders at Davos to commit to rapid global access to revolutionary new long-acting HIV medicines
24 January 2025
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
17 January 2025
Older Stories